Ledger.Open graph →

SEC Form D · filed December 23, 2009

Revance Therapeutics, Inc

Offering

$25.6M

Sold

$25.6M

Exemption

—

Industry

Pharmaceuticals

Location

NEWARK, CA

Type

—

People & firms on this filing (12)

Phyllis Gardner · Newark, CADirector L. D. Browne · Newark, CAExec · Director Vicente Trelles · Newark, CADirector Jim Glasheen · Newark, CADirector Robert Byrnes · Newark, CADirector Frank Kung · Newark, CADirector Joel R. Beaudin · North River, NYExec · Director Dan Beecroft · Boca Raton, FLDirector Blake Beecroft · Boca Raton, FLDirector Toney Jennings · Austin, TXDirector Daniel M. Teal · Austin, TXDirector Richard Teal · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗